1,200 articles
Ian F. Pollack
Ian F. Pollack, also known as Ian Pollack, is a pediatric neurosurgeon at the University of Pittsburgh who led the Children's Oncology Group CNS Tumor Committee from 1999 to 2009.
Ian F. Tannock
Ian F. Tannock is a medical oncologist and Emeritus Professor at Princess Margaret Cancer Centre in Toronto who led trials making docetaxel standard for prostate cancer.
Ian Judson
Ian Judson is a British medical oncologist and Emeritus Professor at the Institute of Cancer Research who led the Royal Marsden sarcoma unit and coordinated EORTC sarcoma trials.
Ian M. Thompson
Ian M. Thompson is an American urologic oncologist at UT Health San Antonio who led the Prostate Cancer Prevention Trial and retired from the Army as a colonel.
Ian Tomlinson
Ian Tomlinson, born 1963, is a British cancer geneticist and Professor of Cancer Genetics at Oxford, known for inherited cancer genes and the 'just right' model.
Ignacio Melero
Ignacio Melero is a Spanish cancer immunologist, Professor of Immunology at the Universidad de Navarra, known for his research on the co-stimulatory molecule 4-1BB (CD137).
Igor B. Roninson
Igor B. Roninson is a cancer researcher known for cloning the mdr1 multidrug resistance gene and discovering the first selective CDK8/19 inhibitors, retiring in 2026 as professor emeritus at the University of South Carolina.
Ilan R. Kirsch
Ilan R. Kirsch is a physician and cancer genetics researcher known for work on aberrant V(D)J recombination in lymphoid leukemia and for immunosequencing at Adaptive Biotechnologies.
Ingegerd Hellström
Ingegerd Hellström is a Swedish-born tumor immunologist and physician-scientist at the University of Washington in Seattle whose laboratory identified the protein mesothelin, now the basis of mesothelioma blood tests.
Ingo K. Mellinghoff
Ingo K. Mellinghoff is a German-trained neuro-oncologist who has chaired the Department of Neurology at Memorial Sloan Kettering Cancer Center since 2020, known for developing targeted therapies for IDH-mutant glioma.
Ira Pastan
Ira Pastan is an American molecular biologist and cancer researcher who founded the National Cancer Institute's Laboratory of Molecular Biology in 1970 and developed recombinant immunotoxins for cancer.
Irwin D. Bernstein
Irwin D. Bernstein is an American pediatric hematologist-oncologist and professor at Fred Hutch Cancer Center in Seattle whose antibody research produced the FDA-approved leukemia drug gemtuzumab ozogamicin.
Isaac Djerassi
Isaac Djerassi (1925–2011) was a Bulgarian-born American physician and cancer researcher who pioneered platelet transfusion support for intensive chemotherapy and high-dose methotrexate treatment, working in Sidney Farber's group in Boston.
Isabelle Soerjomataram
Isabelle Soerjomataram is a medical epidemiologist at the International Agency for Research on Cancer in Lyon, known for GLOBOCAN global cancer estimates and quantifying cancers attributable to alcohol, tobacco, and high body weight.
Ivan Stamenkovic
Ivan Stamenkovic is a Swiss-based pathologist and cancer researcher, professor at CHUV and the University of Lausanne, known for identifying CD44 as the principal receptor for hyaluronate and for Ewing sarcoma research.
Izidore S. Lossos
Izidore S. Lossos is an Israeli-trained hematologist-oncologist who leads the Lymphoma Section at the University of Miami and developed a six-gene survival predictor for diffuse large B-cell lymphoma, published in 2004.
Izrael Hieger
Izrael Hieger (1901–1986) was a biochemist at the Royal Cancer Hospital, later the Royal Marsden, from 1924 to 1966, co-authoring the 1933 isolation of benzo[a]pyrene from coal tar.
J. Silvio Gutkind
J. Silvio Gutkind is a cancer-signaling biologist who chairs Pharmacology at UC San Diego and was elected to the National Academy of Medicine in 2019.
Jaap Verweij
Jaap Verweij is a Dutch medical oncologist, Emeritus Professor and former Dean at Erasmus MC, Rotterdam, known for the EORTC high-dose imatinib trials in GIST and sarcoma drug development.
Jack Cuzick
Jack Cuzick is a British cancer epidemiologist and statistician at Queen Mary University of London who led the IBIS breast cancer prevention trials and was knighted in 2025.
Jack E. White
Jack Edward White (1921–1988) was an American cancer surgeon and Howard University professor who built its NCI-designated cancer center, becoming the first African American to lead one.
Jae U. Jung
Jae U. Jung, also known as Jae Jung, is a virologist and cancer biologist who studies Kaposi's sarcoma-associated herpesvirus and chairs Cancer Biology at Cleveland Clinic.
Jaffer A. Ajani
Jaffer A. Ajani is a gastrointestinal medical oncologist and tenured professor at MD Anderson Cancer Center who has chaired the NCCN esophageal and gastric cancers panel since 1997.
James A. DeCaprio
James A. DeCaprio is an American physician-scientist at Dana-Farber Cancer Institute who showed that SV40 large tumor antigen binds the retinoblastoma protein and identified the DREAM complex.
James Brugarolas
James Brugarolas is a kidney cancer physician-scientist and professor at UT Southwestern whose work on HIF-2 led to belzutifan, first FDA-approved HIF-2 inhibitor for kidney cancer.
James Bumgardner Murphy
James Bumgardner Murphy (1884–1950) was an American cancer researcher who spent his career at the Rockefeller Institute, established the lymphocyte's role in graft rejection, and developed the first technique for growing tumor viruses in hens' eggs.
James C. Yao
James C. Yao, also known as James Yao, is an American medical oncologist specializing in neuroendocrine tumors who chairs GI Medical Oncology at MD Anderson Cancer Center.
James DeGregori
James V. DeGregori is an American molecular biologist and cancer researcher at the University of Colorado, known for the adaptive oncogenesis framework and 2025 work on viruses awakening dormant cancer cells.
James Ewing (pathologist)
James Ewing (1866–1943) was an American pathologist, first professor of pathology at Cornell, best known for describing Ewing sarcoma and founding American cancer research organizations.
James F. Holland
James F. Holland (1925–2018) was an American physician and cancer researcher, a founding father of combination chemotherapy and the modern cooperative clinical trial in oncology.